Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tamoxifen vs Tamoxifen + Aminoglutethimide in Early-stage Breast Cancer
NCT00309491Phase 3Completed
- Sponsor
- Austrian Breast and Colorectal Cancer Study Group
- Start
- Dec 1990
- Primary completion
- Jan 1996
- Modality
- Small Molecules
01
Overview
Phase 3, randomised trial of aminoglutethimide in breast cancer (2 arms), sponsored by Austrian Breast and Colorectal Cancer Study Group. Primary endpoint: Overall survival. Started Dec 1990; status: completed.
02
Drugs
aminoglutethimide
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00309491.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00309491.